The effect of finasteride in the prevention of bladder tumor recurrence
Phase 3
Recruiting
- Conditions
- bladder cancer.Malignant neoplasm of bladder, unspecifiedC67.9
- Registration Number
- IRCT20200608047702N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Patients with bladder tumors, which are candidates of fallow up
Consent to inclusion the study
insensitivity to drug
Patient cooperation during the study
Age 18 to 70 years
Exclusion Criteria
No consent to the inclusion of the study
Loss of patient in f/u
No regular drug use
Patients with underlying disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevention of recurrence of bladder cancer. Timepoint: before intervention and every 3 months for a period of one year. Method of measurement: cystoscopy pathology report.
- Secondary Outcome Measures
Name Time Method